A Study to Evaluate Efficacy and Safety of Zanubrutinib With R-CHOP in Newly Diagnosed Non-GCB DLBCL Patients With Double Expression
Clinical trial NCT05189197 · UNKNOWN
Trial details
- NCT number
- NCT05189197
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-18
- Primary completion
- 2025-01-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.